CVS Health (1CVS) Stock Forecast & Price Target
5 Followers
1CVS Analyst Ratings
Strong Buy
16Buy0Hold0Sell
Based on 16 analysts giving stock ratings to CVS Health in the past 3 months
1CVS Stock 12 Month Forecast
Average Price Target
EUR 101.03â–²(26.03% Upside)Based on 16 Wall Street analysts offering 12 month price targets for CVS Health in the last 3 months. The average price target is EUR 101.03 with a high forecast of EUR 109.42 and a low forecast of EUR 95.19. The average price target represents a 26.03% change from the last price of EUR 80.16.
Past 12 Months12 Month ForecastJan2026Oct2026
HighEUR 109.42
AverageEUR 101.03
LowEUR 95.19
Highest Price TargetHighestEUR 109.42Average Price TargetEUR 101.03Lowest Price TargetLowestEUR 95.19
Detailed List of Analyst Forecasts​
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Andrew Mok CFA | Barclays | EUR 96.08 | buy | 19.86%Upside | Reiterated | 11/04/26 | ||
| Erin Wright | Morgan Stanley | EUR 98.75 | buy | 23.19%Upside | Reiterated | 11/04/26 | ||
| Lance Wilkes | Bernstein | EUR 99.64 | buy | 24.30%Upside | Reiterated | 11/04/26 | ||
| Elizabeth Anderson CFA | Evercore ISI | EUR 111.20→EUR 97.86 | buy | 22.08%Upside | Assigned | 11/04/26 | ||
| Allen Lutz | Bank of America Securities | EUR 97.86 | buy | 22.08%Upside | Reiterated | 11/03/26 | ||
| Stephen Baxter | Wells Fargo | EUR 109.42 | buy | 36.51%Upside | Reiterated | 11/03/26 | ||
| Michael Cherny | Leerink Partners | EUR 105.86→EUR 99.64 | buy | 24.30%Upside | Reiterated | 10/12/26 | ||
| Charles Rhyee | TD Cowen | EUR 97.86 | buy | 22.08%Upside | Reiterated | 10/09/26 | ||
| Ben Hendrix | RBC Capital | EUR 100.53 | buy | 25.41%Upside | Reiterated | 10/07/26 | ||
| Kevin Caliendo | UBS | EUR 112.09→EUR 104.98 | buy | 30.96%Upside | Assigned | 09/03/26 | ||
| Brian Tanquilut | Jefferies | EUR 106.75 | buy | 33.18%Upside | Reiterated | 08/31/26 | ||
| Jessica Tassan | Piper Sandler | EUR 100.53 | buy | 25.41%Upside | Reiterated | 08/26/26 | ||
| Steven Silver | Argus Research | EUR 92.52→EUR 101.42 | buy | 26.52%Upside | Reiterated | 08/18/26 | ||
| Lisa Gill | J.P. Morgan | EUR 98.75→EUR 104.98 | buy | 30.96%Upside | Reiterated | 08/12/26 | ||
| David S Macdonald | Truist Financial | EUR 104.98 | buy | 30.96%Upside | Reiterated | 08/06/26 |
| Rating | Follow | Article | |||
|---|---|---|---|---|---|
| Andrew Mok CFABarclays | BuyReiteratedEUR 96.08 | 11/04/26 | 19.86%Upside | ||
| Erin WrightMorgan Stanley | BuyReiteratedEUR 98.75 | 11/04/26 | 23.19%Upside | ||
| Lance WilkesBernstein | BuyReiteratedEUR 99.64 | 11/04/26 | 24.30%Upside | ||
| Elizabeth Anderson CFAEvercore ISI | BuyAssignedEUR 111.20→EUR 97.86 | 11/04/26 | 22.08%Upside | ||
| Allen LutzBank of America Securities | BuyReiteratedEUR 97.86 | 11/03/26 | 22.08%Upside | ||
| Stephen BaxterWells Fargo | BuyReiteratedEUR 109.42 | 11/03/26 | 36.51%Upside | ||
| Michael ChernyLeerink Partners | BuyReiteratedEUR 105.86→EUR 99.64 | 10/12/26 | 24.30%Upside | ||
| Charles RhyeeTD Cowen | BuyReiteratedEUR 97.86 | 10/09/26 | 22.08%Upside | ||
| Ben HendrixRBC Capital | BuyReiteratedEUR 100.53 | 10/07/26 | 25.41%Upside | ||
| Kevin CaliendoUBS | BuyAssignedEUR 112.09→EUR 104.98 | 09/03/26 | 30.96%Upside | ||
| Brian TanquilutJefferies | BuyReiteratedEUR 106.75 | 08/31/26 | 33.18%Upside | ||
| Jessica TassanPiper Sandler | BuyReiteratedEUR 100.53 | 08/26/26 | 25.41%Upside | ||
| Steven SilverArgus Research | BuyReiteratedEUR 92.52→EUR 101.42 | 08/18/26 | 26.52%Upside | ||
| Lisa GillJ.P. Morgan | BuyReiteratedEUR 98.75→EUR 104.98 | 08/12/26 | 30.96%Upside | ||
| David S MacdonaldTruist Financial | BuyReiteratedEUR 104.98 | 08/06/26 | 30.96%Upside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering CVS Health
3 Months
Success Rate14/20 ratings generated profit
70%
Average Return
+11.79%
Copying Stephen Baxter's trades and holding each position for 3 Months would result in 70.00% of your transactions generating a profit, with an average return of +11.79% per trade.
1 Year
Success Rate16/20 ratings generated profit
80%
Average Return
+26.58%
Copying Stephen Baxter's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +26.58% per trade.
2 Years
Success Rate25/29 ratings generated profit
86%
Average Return
+32.08%
Copying Allen Lutz's trades and holding each position for 2 Years would result in 86.21% of your transactions generating a profit, with an average return of +32.08% per trade.
1CVS Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 37 | 36 | 35 | 32 | 19 |
| Hold | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 38 | 37 | 36 | 32 | 19 |
In the current month, 1CVS has received 19 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 1CVS average Analyst price target in the past 3 months is 101.03.
1CVS Financial Forecast
HighEUR 1.21
ConsensusEUR 1.10
LowEUR 0.93
1CVS Earnings Forecast
Next quarter’s earnings estimate for 1CVS is EUR 1.10 with a range of EUR 0.93 to EUR 1.21. The previous quarter’s EPS was EUR 1.86. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighEUR 99.8B
ConsensusEUR 95.2B
LowEUR 92.6B
1CVS Sales Forecast
Next quarter’s sales forecast for 1CVS is EUR 95.20B with a range of EUR 92.59B to EUR 99.80B. The previous quarter’s sales results were EUR 96.43B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
1CVS Stock Forecast FAQ
What is IT:1CVS’s average 12-month price target, according to analysts?
Based on analyst ratings, CVS Health’s 12-month average price target is €101.03.
What is IT:1CVS’s upside potential, based on the analysts’ average price target?
CVS Health has 26.03% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CVS Health a Buy, Sell or Hold?
CVS Health has a consensus rating of Strong Buy, which is based on 16 buy ratings, 0 hold ratings and 0 sell ratings.
What is CVS Health’s share price target?
The average share price target for CVS Health is €101.03. This is based on 16 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €109.42, and the lowest forecast is €95.19. The average share price target represents a 26.03% increase from the current price of €80.16.
What do analysts say about CVS Health?
CVS Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 16 Wall Street analysts.
How can I buy shares of CVS Health?
To buy shares of IT:1CVS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
